InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+21.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Karim Dabbagh, Président. Insider active across 1 company, notably MAAT PHARMA. Cumulatively, 1 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 22 December 2023. The latest transaction was disclosed on 22 December 2023 (Acquisition). Regulator: AMF. The full history is accessible without signup.
Companies and markets linked to Karim Dabbagh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
1,960 股@ €5.10100.0% 占其流量ActionEuronext ParisISIN FR00126348222024DD946682
标准退出：2024年3月21日 (T+90)
1 条申报中的 1 条
About Karim Dabbagh
Karim Dabbagh is the Independent Chairman of the Board at Maat Pharma. In this role, he oversees the activities of the board and ensures the governance of the company. His experience in the pharmaceutical sector and strategic vision are essential for guiding Maat Pharma towards its objectives.
